ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT side effect
What is ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT and Recently Reported Side Effects
ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT and 15 most Active Side Effect polls
ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT
CUBICIN ETHYOL INFLIXIMAB LINEZOLID MYCAMINECubicin Side Effects Report #5517421-6
Pharmacist from UNITED STATES reported CUBICIN problem on July 25, 2007. Male patient, 59 years of age, weighting 200.0 lb, was diagnosed with bacteraemia, endocarditis and was treated with CUBICIN. After drug was administered, patient experienced the following problems/side effects: antimicrobial susceptibility test resistant, bacteraemia, . CUBICIN dosage: 3.5MG/KG;Q24H;IV. During the same period patient was treated with ATENOLOL, REPAGLINIDE, FERROUS SULPHATE, PANTOPRAZOLE, ALDACTONE, LIDODERM, DARVOCET. Patient was hospitalized. Patient recovered.
Cubicin Side Effects Report #5517429-0
CUBICIN problem was reported by a Physician from UNITED STATES on May 30, 2007. Female patient, 83 years of age, weighting 132.3 lb, was diagnosed with endocarditis staphylococcal, staphylococcal bacteraemia and was treated with CUBICIN. After drug was administered, patient experienced the following problems/side effects: antimicrobial susceptibility test resistant, bacteraemia, . CUBICIN dosage: 6 MG/KG;Q24H;IV. During the same period patient was treated with DILTIAZEM, ATENOLOL, CLONIDINE, FUROSEMIDE, PREDNISONE, PANTOPRAZOLE, VANCOMYCIN. Patient recovered.
Ethyol Side Effects Report #5457802-2
Health Professional from UNITED STATES reported ETHYOL problem on Sept 07, 2007. Female patient, 71 years of age, was diagnosed with lip and/or oral cavity cancer and was treated with ETHYOL. After drug was administered, patient experienced the following problems/side effects: antimicrobial susceptibility test resistant, injection site erythema, mucosal inflammation, neutropenia, oral mucosa erosion, sepsis, staphylococcal infection, . ETHYOL dosage: 500 MG, 5 IN 5 D, SUBCUTANEOUS; 500 MG, 5 IN 5 D, SUBCUTANEOUS. During the same period patient was treated with ZOFRAN, CLARITIN, SEGILINE. Patient was hospitalized. Patient died on 08/13/2007.
Cubicin Side Effects Report #5463571-2
CUBICIN problem was reported by a Physician from UNITED STATES on Sept 05, 2007. Female patient, 51 years of age, was diagnosed with staphylococcal bacteraemia and was treated with CUBICIN. After drug was administered, patient experienced the following problems/side effects: antimicrobial susceptibility test resistant, cardiac valve vegetation, endocarditis staphylococcal, mitral valve disease, multi-organ failure, no therapeutic response, treatment failure, . CUBICIN dosage: 6 MG/KG; Q24H; IV. During the same period patient was treated with VANCOMYCIN. Patient recovered.
Cubicin Side Effects Report #5389387-3
Physician from UNITED STATES reported CUBICIN problem on July 13, 2007. Male patient, 57 years of age, weighting 204.0 lb, was diagnosed with endocarditis, staphylococcal sepsis, thrombophlebitis and was treated with CUBICIN. After drug was administered, patient experienced the following problems/side effects: antimicrobial susceptibility test resistant, disease recurrence, endocarditis, staphylococcal bacteraemia, . CUBICIN dosage: 6MG/KG = 560MG Q24H IV, 6MG/KG. Patient died on 04/20/2007.
Linezolid Side Effects Report #5392728-4
LINEZOLID problem was reported by a Consumer or non-health professional from SPAIN on July 10, 2007. Male patient, 25 years of age, was treated with LINEZOLID. After drug was administered, patient experienced the following problems/side effects: antimicrobial susceptibility test resistant, . LINEZOLID dosage: unknown. During the same period patient was treated with PIPERACILLIN AND TAZOBACTAM, METRONIDAZOLE, GENTAMICIN, TEICOPLANIN, MEROPENEM. Patient recovered.
Cubicin Side Effects Report #5389387-3
Physician from UNITED STATES reported CUBICIN problem on July 13, 2007. Male patient, 57 years of age, weighting 204.0 lb, was diagnosed with endocarditis, staphylococcal sepsis, thrombophlebitis and was treated with CUBICIN. After drug was administered, patient experienced the following problems/side effects: antimicrobial susceptibility test resistant, disease recurrence, endocarditis, staphylococcal bacteraemia, . CUBICIN dosage: 6MG/KG = 560MG Q24H IV, 6MG/KG. Patient died on 04/20/2007.
Linezolid Side Effects Report #5392728-4
LINEZOLID problem was reported by a Consumer or non-health professional from SPAIN on July 10, 2007. Male patient, 25 years of age, was treated with LINEZOLID. After drug was administered, patient experienced the following problems/side effects: antimicrobial susceptibility test resistant, . LINEZOLID dosage: unknown. During the same period patient was treated with PIPERACILLIN AND TAZOBACTAM, METRONIDAZOLE, GENTAMICIN, TEICOPLANIN, MEROPENEM. Patient recovered.
Cubicin Side Effects Report #5743739-8
Physician from UNITED STATES reported CUBICIN problem on Feb 21, 2008. Female patient was diagnosed with staphylococcal bacteraemia, staphylococcal osteomyelitis and was treated with CUBICIN. After drug was administered, patient experienced the following problems/side effects: antimicrobial susceptibility test resistant, underdose, . CUBICIN dosage: 2 MG/KG;IV. Patient was hospitalized. Patient recovered.
Cubicin Side Effects Report #5373975-4
CUBICIN problem was reported by a Physician from UNITED STATES on June 14, 2007. Male patient, 57 years of age, was diagnosed with bacteraemia, thrombophlebitis septic and was treated with CUBICIN. After drug was administered, patient experienced the following problems/side effects: antimicrobial susceptibility test resistant, echocardiogram abnormal, endocarditis, hypotension, mitral valve disease, pyrexia, staphylococcal bacteraemia, tricuspid valve disease, . CUBICIN dosage: 6 MG/KG; Q24H; IV. During the same period patient was treated with VANCOMYCIN, LINEZOLID. Patient died on 04/20/2007.
Cubicin Side Effects Report #5350030-0
Health Professional from UNITED STATES reported CUBICIN problem on Jan 08, 2007. Male patient was diagnosed with device related infection, endocarditis, pathogen resistance, staphylococcal bacteraemia and was treated with CUBICIN. After drug was administered, patient experienced the following problems/side effects: antimicrobial susceptibility test resistant, staphylococcal bacteraemia, thrombocytopenia, . CUBICIN dosage: 6 MG/KG; Q24H; IV. During the same period patient was treated with VANCOMYCIN. Patient recovered.
Mycamine Side Effects Report #5457524-8
MYCAMINE problem was reported by a Health Professional from UNITED STATES on Sept 04, 2007. Female patient, 47 years of age, was diagnosed with systemic candida and was treated with MYCAMINE. After drug was administered, patient experienced the following problems/side effects: abdominal sepsis, antimicrobial susceptibility test resistant, cardiac valve vegetation, systemic candida, . MYCAMINE dosage: 150 MG, UID/QD,. During the same period patient was treated with CASPOFUNGIN. Patient was hospitalized. Patient recovered.
Infliximab Side Effects Report #5409529-0
Pharmacist from UNITED STATES reported INFLIXIMAB problem on Aug 08, 2007. Male patient, 60 years of age, weighting 199.0 lb, was diagnosed with colitis ulcerative and was treated with INFLIXIMAB. After drug was administered, patient experienced the following problems/side effects: alpha haemolytic streptococcal infection, antimicrobial susceptibility test resistant, arthralgia, chills, joint stiffness, musculoskeletal stiffness, night sweats, pyrexia, rash, . INFLIXIMAB dosage: 500MG EVERY 8 WEEKS IV. Patient was hospitalized. Patient recovered.
Cubicin Side Effects Report #5397060-0
CUBICIN problem was reported by a Physician from UNITED STATES on July 12, 2007. Male patient, 57 years of age, weighting 204.4 lb, was diagnosed with bacteraemia, endocarditis, thrombophlebitis septic and was treated with CUBICIN. After drug was administered, patient experienced the following problems/side effects: alcoholic liver disease, antimicrobial susceptibility test resistant, aortic valve incompetence, blood alkaline phosphatase increased, echocardiogram abnormal, endocarditis, fibrin d dimer increased, haematocrit decreased, haemoglobin decreased, . CUBICIN dosage: 6 MG/KG;Q24H;IV. During the same period patient was treated with VANCOMYCIN, ZYVOX, XIGRIS, CEFTRIAXONE, CEFDINIR. Patient was hospitalized. Patient died on 04/20/2007.
Cubicin Side Effects Report #5397060-0
Physician from UNITED STATES reported CUBICIN problem on July 12, 2007. Male patient, 57 years of age, weighting 204.4 lb, was diagnosed with bacteraemia, endocarditis, thrombophlebitis septic and was treated with CUBICIN. After drug was administered, patient experienced the following problems/side effects: alcoholic liver disease, antimicrobial susceptibility test resistant, aortic valve incompetence, blood alkaline phosphatase increased, echocardiogram abnormal, endocarditis, fibrin d dimer increased, haematocrit decreased, haemoglobin decreased, . CUBICIN dosage: 6 MG/KG;Q24H;IV. During the same period patient was treated with VANCOMYCIN, ZYVOX, XIGRIS, CEFTRIAXONE, CEFDINIR. Patient was hospitalized. Patient died on 04/20/2007.